Government & Policy

A newly established research centre is building a chronic disease management system to enable access to comprehensive patient data.

The American Hospital Association questions the agency's calculations, and said the proposed information blocking penalties could threaten the financial viability of many small and rural hospitals.

With guidelines and rules for healthcare AI coming from the FDA, ONC, OCR, the White House and others, how will this regulatory framework change in 2024? Bryant Godfrey, partner at Foley Hoag, offers some thoughts.  

The Medical Group Management Association says ONC's proposed rules add undue financial burden to practices and would affect the delivery of Medicare and value-based care.

Andreessen Horowitz investment partner Jay Rughani discusses the paper he and his colleagues published recently about clinical use cases of AI, and outlined steps regulators should take for reimbursing providers using the technology.

With HTI-1 finalized, EHR vendors will have to tackle electronic case reporting while providers must look ahead and get social determinants of health into their workflows, says Don Rucker, chief strategy officer for 1upHealth.  

A new law passed in New York and legislation introduced in Ohio are just two of the latest examples of a legislative push to expand insurance coverage for biomarker testing.

The year ahead will see policies evolving along with the tech, says Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, who discusses regulatory approaches that foster innovation while protecting safety.  

The watchdog agency said that it found the existing coordination agreement does not reflect "organizational and procedural changes," including the FDA's authority to find that medical devices in use violate federal law.